AstraZeneca sales of Covid vaccine triple to $1.2bn in first half of 2021 – The Guardian
AstraZenecaNot-for-profit pledge sees British firms sales revenue fall significantly short of US rival Pfizer
Thu 29 Jul 2021 15.58 BST
AstraZeneca has reported a threefold rise in sales of its Covid-19 vaccine from the first quarter of 2021 to the second…
